CSI Market
Sign In | Register

Ani Pharmaceuticals Inc (ANIP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ANIP Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Ani Pharmaceuticals Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ANIP/balance-sheets
https://api.csimarket.com/api/v1/companies/ANIP/fundamentals
https://api.csimarket.com/api/v1/companies/ANIP/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent420.76
Restricted Cash0.04
Cash & Short-term Investments420.00
Accounts receivable304.45
Inventories136.41
Other Current Assets15.59
Prepaid Expense, Current AS25.58
Total Current Assets902.82
Equipment/Property/Plant Net81.55
Goodwill net62.48
Intangible Assets433.11
Other Assets, Noncurrent87.70
Total Assets1,567.66
Liabilities
Accounts Payable, Current AC74.42
Accrued Liabilities, Current34.95
Long-term Debt, Current Maturities LO23.36
Other Liabilities, Current187.01
Taxes Payable, Current, Total8.98
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities328.72
Long-term debt274.31
Total Long-term Debt274.31
Other liabilities, Noncurrent327.52
Returned Goods Reserve43.05
Total Liabilities930.55
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock634.24
Retained Earnings / Accumulated Deficit66.25
Accumulated Other Comprehensive Income-1.17
Other Equity-1.17
Common Stockholder's Equity637.11
Total Stockholder's Equity637.11
Liabilities & Stockholder's Equity1,567.66
4 historic quarters locked

Sign in to unlock the full Ani Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Ani Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001023024-26-000078

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI